ACLARION, INC. Increase (Decrease) in Accounts Payable
ACLARION, INC. (ACON) reported Increase (Decrease) in Accounts Payable of $372.84 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- ACLARION, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $130.65K.
- ACLARION, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $242.19K.
- ACLARION, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $15.37K, a 94.64% decline year-over-year.
- ACLARION, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $54.23K, a 44.46% decline year-over-year.
- ACLARION, INC. increase (decrease) in accounts payable for fiscal 2025 was -$198.64K.
- ACLARION, INC. increase (decrease) in accounts payable for fiscal 2024 was -$156.40K, a 170.89% decline from fiscal 2023.
- ACLARION, INC. increase (decrease) in accounts payable for fiscal 2023 was $220.63K.
- ACLARION, INC. increase (decrease) in accounts payable for fiscal 2022 was -$603.10K, a 402.15% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $130.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $372.84K 10-Q · filed 2026-08-06 | $388.21K derived: sum of 3 quarters · filed 2026-08-06 | $442.44K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $242.19K 10-Q · filed 2026-05-13 | $257.56K derived: sum of 2 quarters · filed 2026-05-13 | $311.79K derived: sum of 3 quarters · filed 2026-05-13 | $58.89K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $15.37K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $69.60K derived: sum of 2 quarters · filed 2026-03-18 | -$183.31K derived: sum of 3 quarters · filed 2026-08-06 | -$198.64K 10-K · filed 2026-03-18 |
| 2025-09-30 | $54.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$198.67K derived: sum of 2 quarters · filed 2026-08-06 | -$214.01K 10-Q · filed 2025-11-12 | $72.66K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$252.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$268.24K 10-Q · filed 2026-08-06 | $18.43K derived: sum of 3 quarters · filed 2026-08-06 | $116.07K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$15.33K 10-Q · filed 2026-05-13 | $271.33K derived: sum of 2 quarters · filed 2026-05-13 | $368.97K derived: sum of 3 quarters · filed 2026-05-13 | $468.43K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $286.67K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $384.31K derived: sum of 2 quarters · filed 2026-03-18 | $483.76K derived: sum of 3 quarters · filed 2026-03-18 | -$156.40K 10-K · filed 2026-03-18 |
| 2024-09-30 | $97.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $197.09K derived: sum of 2 quarters · filed 2025-11-12 | -$443.07K 10-Q · filed 2025-11-12 | -$430.21K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $99.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$540.71K 10-Q · filed 2025-08-14 | -$527.85K derived: sum of 3 quarters · filed 2025-08-14 | -$377.99K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$640.16K 10-Q · filed 2025-05-15 | -$627.30K derived: sum of 2 quarters · filed 2025-05-15 | -$477.44K derived: sum of 3 quarters · filed 2025-05-15 | -$502.07K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $12.86K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-09 | $162.72K derived: sum of 2 quarters · filed 2025-04-09 | $138.09K derived: sum of 3 quarters · filed 2025-04-09 | $220.63K 10-K · filed 2025-04-09 |
| 2023-09-30 | $149.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $125.23K derived: sum of 2 quarters · filed 2024-11-14 | $207.77K 10-Q · filed 2024-11-14 | -$48.30K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$24.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $57.91K 10-Q · filed 2024-08-14 | -$198.16K derived: sum of 3 quarters · filed 2024-08-14 | -$664.26K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $82.54K 10-Q · filed 2024-05-15 | -$173.54K derived: sum of 2 quarters · filed 2024-05-15 | -$639.63K derived: sum of 3 quarters · filed 2024-05-15 | -$847.64K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$256.08K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$722.17K derived: sum of 2 quarters · filed 2024-03-28 | -$930.18K derived: sum of 3 quarters · filed 2024-03-28 | -$603.10K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$466.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$674.11K derived: sum of 2 quarters · filed 2023-11-14 | -$347.03K 10-Q · filed 2023-11-14 | -$305.25K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$208.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-25 | $119.07K 10-Q · filed 2023-08-25 | $160.85K derived: sum of 3 quarters · filed 2023-08-25 | |
| 2022-03-31 | $327.08K 10-Q · filed 2023-07-03 | $368.85K derived: sum of 2 quarters · filed 2023-07-03 | ||
| 2021-12-31 | $41.77K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-12 | $199.60K 10-K/A · filed 2023-06-12 | ||
| 2021-09-30 | $157.83K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |